A Mime To Kill: *Everyone Hates A Mime*
*Media Release*
A Mime To Kill: *Everyone Hates A Mime*
*A Mime To Kill*
BATS Theatre, Kent Terrace
Feb 7-10 9.30pm
*The Magniloquents* return to BATS Theatre as part of Fringe 09 with *A MIME TO KILL*, a new devised black comedy investigating the plight of a Mime who opens one door too many and accidentally finds himself ensnared in the real world.
*A MIME* *TO KILL* brings together the producers of *aoTERRORoa* and *TAP THAT II – The Reckoning*.
Recent Toi Whakaari: NZ Drama School graduates Sam Bunkall, Hadleigh Walker and Byron Coll star in this original New Zealand work investigating the divide between the real and the imaginary and the helplessness of being trapped in between.
*A MIME TO KILL* blends surrealism, doco-theatre and mime to create a story that is witty, fresh and universal, showing the audience what is really behind the paint, the stripes and the lippy.
*"You know what, I didn't ask to be born like this. I never had a choice. People see my white face and red lips...and they just laugh. Have you ever felt that level of humiliation? Strangers pointing. Leering. Mocking. I feel like the poor fat kid at school that's too heavy to play on the swings. Now I know how Jesus felt."*
-Marcel Marceaux
A MIME TO KILL
BATS Theatre, Kent Terrace
Feb 7-10 9.30pm
Tickets $16/$12/$10
Email: book@bats.co.nz
Phone: 04 802 4175
Made possible by Kakano Funding
ENDS
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future
Dry July: Thousands Set To Go Alcohol Free This July As Cancer Diagnoses Continue To Rise Across Aotearoa
New Zealand College of Midwives: Celebrating Midwives Across Aotearoa This International Day Of The Midwife
PPTA Te Wehengarua: Building The Secondary Curriculum On Broken Drafts Is A Serious Risk
Whanganui Regional Museum: Whanganui Makers Bring Textile Traditions To Life During Symposium Weekend
Palmerston North Hospital Foundation: Fundraising For Publicly-Owned Surgical Robot Hits $2 Million Milestone In Less Than Three Months